D-0279-2025 Class II
FDA drug recall D-0279-2025 was initiated by Slate Run Pharmaceuticals on Mar 7, 2025 and is designated Class II. Reason for recall: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits. Affected quantity: 2,444 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 26, 2025
- Initiation Date
- Mar 7, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,444 bottles
Product description
Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04
Reason for recall
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Distribution pattern
Product was distributed to 8 distributors who may have further distribute the product nationwide.
Code information
Lot # 109797, Exp 11/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0279-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026